SE327047B - - Google Patents
Info
- Publication number
- SE327047B SE327047B SE05049/61A SE504961A SE327047B SE 327047 B SE327047 B SE 327047B SE 05049/61 A SE05049/61 A SE 05049/61A SE 504961 A SE504961 A SE 504961A SE 327047 B SE327047 B SE 327047B
- Authority
- SE
- Sweden
- Prior art keywords
- polar solvent
- therapeutic agent
- aluminium salt
- gel
- cellulose acetate
- Prior art date
Links
- 159000000013 aluminium salts Chemical class 0.000 abstract 14
- 239000003814 drug Substances 0.000 abstract 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 12
- 229910000329 aluminium sulfate Inorganic materials 0.000 abstract 12
- 229940124597 therapeutic agent Drugs 0.000 abstract 12
- 229920000623 Cellulose acetate phthalate Polymers 0.000 abstract 10
- 229940081734 cellulose acetate phthalate Drugs 0.000 abstract 10
- 239000012454 non-polar solvent Substances 0.000 abstract 10
- 239000002798 polar solvent Substances 0.000 abstract 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 6
- 239000011877 solvent mixture Substances 0.000 abstract 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 239000000126 substance Substances 0.000 abstract 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 abstract 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 abstract 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 2
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 abstract 2
- VJNXVAVKCZJOFQ-UHFFFAOYSA-N Phenmetrazine hydrochloride Chemical compound Cl.CC1NCCOC1C1=CC=CC=C1 VJNXVAVKCZJOFQ-UHFFFAOYSA-N 0.000 abstract 2
- 229920002472 Starch Polymers 0.000 abstract 2
- 229930003779 Vitamin B12 Natural products 0.000 abstract 2
- -1 acetate-phthalate ester Chemical class 0.000 abstract 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000001913 cellulose Substances 0.000 abstract 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 2
- 238000013270 controlled release Methods 0.000 abstract 2
- 239000002285 corn oil Substances 0.000 abstract 2
- 235000005687 corn oil Nutrition 0.000 abstract 2
- 239000003246 corticosteroid Substances 0.000 abstract 2
- 229960001334 corticosteroids Drugs 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 235000003891 ferrous sulphate Nutrition 0.000 abstract 2
- 239000011790 ferrous sulphate Substances 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- 210000004051 gastric juice Anatomy 0.000 abstract 2
- 150000008282 halocarbons Chemical class 0.000 abstract 2
- 238000010438 heat treatment Methods 0.000 abstract 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 abstract 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 150000002576 ketones Chemical class 0.000 abstract 2
- 229960000907 methylthioninium chloride Drugs 0.000 abstract 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 abstract 2
- 125000005474 octanoate group Chemical group 0.000 abstract 2
- 239000003921 oil Substances 0.000 abstract 2
- 235000019198 oils Nutrition 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 229960002315 phenmetrazine hydrochloride Drugs 0.000 abstract 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 2
- 229960002695 phenobarbital Drugs 0.000 abstract 2
- 150000002990 phenothiazines Chemical class 0.000 abstract 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract 2
- 229940070891 pyridium Drugs 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 239000008107 starch Substances 0.000 abstract 2
- 235000019698 starch Nutrition 0.000 abstract 2
- 229920002554 vinyl polymer Polymers 0.000 abstract 2
- 239000011715 vitamin B12 Substances 0.000 abstract 2
- 235000019163 vitamin B12 Nutrition 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2957560A | 1960-05-17 | 1960-05-17 | |
| US106152A US3101293A (en) | 1960-05-17 | 1961-04-28 | Controlled release compositions and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE327047B true SE327047B (enExample) | 1970-08-10 |
Family
ID=26705096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE05049/61A SE327047B (enExample) | 1960-05-17 | 1961-05-15 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3101293A (enExample) |
| BE (1) | BE603851A (enExample) |
| CH (1) | CH448385A (enExample) |
| GB (1) | GB984114A (enExample) |
| NL (1) | NL264748A (enExample) |
| SE (1) | SE327047B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3242049A (en) * | 1963-05-20 | 1966-03-22 | Ncr Co | Process for making enterically useful complex of spiramycin and product thereof |
| US3350270A (en) * | 1964-09-18 | 1967-10-31 | Leeds Dixon Lab Inc | Aluminum aspirin film-enveloped therapeutic agents in sustained release dosage form |
| GB1359643A (en) * | 1970-09-28 | 1974-07-10 | Controlled Medications | Controlled release medicament |
| JPS55153715A (en) * | 1979-05-18 | 1980-11-29 | Nikken Kagaku Kk | Prolonged granule of theophylline |
| JPS6056122B2 (ja) * | 1980-05-21 | 1985-12-09 | 塩野義製薬株式会社 | 徐放性製剤 |
| CN108272766B (zh) * | 2018-03-21 | 2020-07-07 | 江苏四环生物制药有限公司 | 一种甲钴胺分散迟释片及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2805977A (en) * | 1955-01-04 | 1957-09-10 | Smith Kline French Lab | Sustained release pharmaceutical preparation |
| US2928769A (en) * | 1957-07-22 | 1960-03-15 | Strong Cobb And Company Inc | Production of controlled release medicaments |
| US2987445A (en) * | 1958-10-10 | 1961-06-06 | Rohm & Haas | Drug composition |
-
0
- NL NL264748D patent/NL264748A/xx unknown
-
1961
- 1961-04-28 US US106152A patent/US3101293A/en not_active Expired - Lifetime
- 1961-05-09 GB GB16903/61A patent/GB984114A/en not_active Expired
- 1961-05-15 SE SE05049/61A patent/SE327047B/xx unknown
- 1961-05-16 CH CH571461A patent/CH448385A/fr unknown
- 1961-05-16 BE BE603851A patent/BE603851A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL264748A (enExample) | |
| US3101293A (en) | 1963-08-20 |
| BE603851A (fr) | 1961-09-18 |
| GB984114A (en) | 1965-02-24 |
| CH448385A (fr) | 1967-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4722941A (en) | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof | |
| US4176179A (en) | Method for treating arthritis | |
| Mullins et al. | Some pharmaceutical properties of novobiocin | |
| JP4020331B2 (ja) | ガラス形成性担体に溶解した活性物質からなる組成物及びその製造方法 | |
| US4289751A (en) | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof | |
| JP2738936B2 (ja) | 被覆徐放製剤 | |
| Sedgwick et al. | Stimulus-dependent inhibition of superoxide generation by prostaglandins | |
| JPS6344525A (ja) | 全身作用を有する経口治療組成物及びその製造方法 | |
| JPS61189230A (ja) | エトポシド製剤 | |
| US4202888A (en) | Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof | |
| KR930005622A (ko) | 레이슈마니아증을 치료하는데 경구 또는 국소 투여시키기 위한 약리학적 시약을 생산하는 방법 | |
| JPH0367045B2 (enExample) | ||
| GB1005329A (en) | Process for the preparation of sustained release pharmaceutical tablets | |
| GB984114A (en) | Controlled release compositions and their preparation | |
| KR920019351A (ko) | 생리주기에 영향을 미치지 않는 영장류 암컷의 피임방법 | |
| US5728403A (en) | Coating technology for taste masking orally administered bitter drugs | |
| US2218591A (en) | Vitamin preparation | |
| US2566200A (en) | Oral therapeutic tablets | |
| DE2336807A1 (de) | Darmloesliche kapseln | |
| Fenn et al. | Misoprostol—a logical therapeutic approach to gastroduodenal mucosal injury induced by non‐steroidal anti‐inflammatory drugs? | |
| US4657910A (en) | Treatment of cerebrovascular disorders and/or disorders associated with cerebral senility | |
| JPS6024767B2 (ja) | 腸溶性硬カプセル剤 | |
| KR870010082A (ko) | 구아르(guar) 분말 | |
| JPS58154548A (ja) | アズレン誘導体の安定化方法 | |
| NL7905708A (nl) | Farmaceutisch preparaat. |